Abstract

PurposeOligodendrogliomas are heterogeneous tumors in terms of imaging appearance, and a deeper understanding of the histopathological tumor characteristics in correlation to imaging parameters is needed. We used PET-to-MRI-to-histology co-registration with the aim of studying intra-tumoral 11C-methionine (MET) uptake in relation to tumor perfusion and the protein expression of histological cell markers in corresponding areas.MethodsConsecutive histological sections of four tumors covering the entire en bloc-removed tumor were immunostained with antibodies against IDH1-mutated protein (tumor cells), Ki67 (proliferating cells), and CD34 (blood vessels). Software was developed for anatomical landmarks-based co-registration of subsequent histological images, which were overlaid on corresponding MET PET scans and MRI perfusion maps. Regions of interest (ROIs) on PET were selected throughout the entire tumor volume, covering hot spot areas, areas adjacent to hot spots, and tumor borders with infiltrating zone. Tumor-to-normal tissue (T/N) ratios of MET uptake and mean relative cerebral blood volume (rCBV) were measured in the ROIs and protein expression of histological cell markers was quantified in corresponding regions. Statistical correlations were calculated between MET uptake, rCBV, and quantified protein expression.ResultsA total of 84 ROIs were selected in four oligodendrogliomas. A significant correlation (p < 0.05) between MET uptake and tumor cell density was demonstrated in all tumors separately. In two tumors, MET correlated with the density of proliferating cells and vessel cell density. There were no significant correlations between MET uptake and rCBV, and between rCBV and histological cell markers.ConclusionsThe MET uptake in hot spots, outside hotspots, and in infiltrating tumor edges unanimously reflects tumor cell density. The correlation between MET uptake and vessel density and density of proliferating cells is less stringent in infiltrating tumor edges and is probably more susceptible to artifacts caused by larger blood vessels surrounding the tumor. Although based on a limited number of samples, this study provides histological proof for MET as an indicator of tumor cell density and for the lack of statistically significant correlations between rCBV and histological cell markers in oligodendrogliomas.

Highlights

  • Oligodendrogliomas are glial tumors believed to originate from oligodendrocytes, and are further classified based on molecular tumor features [1]

  • We have recently described a new method for co-registration of MR images and histological images in en bloc surgically removed gliomas, allowing region-by-region comparisons of the entire tumor with infiltrating tumor edge [22]

  • These 84 Regions of interest (ROIs) covered a total number of 2134 histological sub-images in which protein expression of three histological cell markers (IDH1, Ki67, and CD34) was quantified

Read more

Summary

Introduction

Oligodendrogliomas are glial tumors believed to originate from oligodendrocytes, and are further classified based on molecular tumor features [1]. Classical oligodendrogliomas are characterized by isocitrate dehydrogenase (IDH) gene mutations and codeletions on chromosome 1p/19q. In the absence of diagnostic molecular testing, oligodendrogliomas are classified as oligodendrogliomas NOS (not-otherwisespecified), while IDH mutated non-codeleted gliomas are classified as astrocytomas [2]. Primary treatment is maximal safe resection, followed by radiotherapy and chemotherapy for highrisk patients [4, 5]. Based on their chemosensitivity, it has recently been suggested that chemotherapy may be the optimal primary treatment for oligodendrogliomas [6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.